506414 — Fermenta Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹6.83bn
- IN₹7.58bn
- IN₹3.36bn
- 86
- 30
- 89
- 82
Annual cashflow statement for Fermenta Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 434 | 516 | 269 | -519 | -98.7 |
| Depreciation | |||||
| Non-Cash Items | 190 | 193 | 176 | 919 | 568 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -430 | -280 | -267 | 484 | 337 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 345 | 632 | 434 | 1,167 | 1,053 |
| Capital Expenditures | -685 | -553 | -371 | -405 | -192 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 248 | 137 | 111 | -158 | 37.1 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -437 | -415 | -260 | -563 | -155 |
| Financing Cash Flow Items | -218 | -175 | -167 | -205 | -167 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -474 | -11.4 | -216 | -408 | -909 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -566 | 205 | -41.7 | 196 | -10 |